Besides its effect on Bsep expression, 4-PB treatment significantly increased hepatic MRP2 and decreased serum bilirubin level in patient with ornithine transcarbamylase deficiency (OTCD) [94]. This evidence concerns the gene ABCC2 and ornithine carbamoyltransferase deficiency.